HIMS
Hims & Hers Health, Inc.
Hims & Hers is a direct-to-consumer telehealth and prescription platform whose growth hinges on telehealth deregulation, online prescribing rules, and compounded-drug policy.
Next filing → your inbox
Govt Dependence
12/100
Regulatory Density
68/100
Lobbying Intensity
22/100
Political Signal
MEDIUM
BusinessWhat HIMS does
Hims & Hers operates a subscription-based telehealth platform selling prescription and OTC treatments for sexual health, hair loss, weight loss (including GLP-1s), mental health, and dermatology. Revenue is primarily recurring consumer subscriptions plus affiliated pharmacy fulfillment.
12 months past · 3 months futureHIMS activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
247 trading days ·
0 congressional trades shown
·
0 insider buys
·
7 13F filings
·
0 past bill actions
·
9 upcoming markups
Executive Branch ConflictsHIMS held by Trump-administration officials
1 cabinet/senior official reported HIMS positions in OGE Form 278 disclosures across 7 filings.
Donald J. Trump
President · White House
HIMS & HERS HEALTH INC
Donald J. Trump
President · White House
HIMS & HERS HEALTH INC
Donald J. Trump
President · White House
HIMS & HERS HEALTH INC
Donald J. Trump
President · White House
HIMS & HERS HEALTH INC
Donald J. Trump
President · White House
HIMS & HERS HEALTH INC
Donald J. Trump
President · White House
HIMS & HERS HEALTH INC
Donald J. Trump
President · White House
HIMS & HERS HEALTH INC
Lifetime Government AwardsHIMS federal contracts
HIMS doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding HIMS
$315.6M
Total HIMS held by tracked 13F funds
3
Funds with HIMS positions
Citadel Advisors
$216M
holds
2025-12-31
D.E. Shaw & Co.
$99M
+25%
2025-12-31
Bridgewater Associates
$210K
-95%
2025-12-31
Politicians Trading HIMSMembers of Congress with recent HIMS positions
1 politicians traded HIMS across 2 disclosed transactions totaling $16K (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just HIMS). 0-30 LOW · 30-60 MID · 60+ HIGH.
Congressional TradesWho in Congress is trading HIMS
2025-08-04
Lisa C. McClain
Purchase
$1,001 - $15,000
2025-08-04
Lisa C. McClain
purchase
$1,001 - $15,000
2+ trades on file · most recent 2025-09-12
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting HIMSLive legislation impacting this stock
HR.661 · 119th
MIRACLE Medical Technology Act of 2025
S.708 · 118th
A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.
S.574 · 118th
Increasing Prescription Drug Competition Act
S.669 · 118th
Increasing Mental Health Options Act of 2023
S.754 · 118th
Improving Mental Health and Wellness in Schools Act
S.731 · 118th
TELEHEALTH HSA Act of 2023
SRES.90 · 118th
A resolution recognizing the significance of endometriosis as an unmet chronic disease for women and designating March 2023 as "En
S.606 · 118th
Protecting Americans from Dangerous Opioids Act
S.604 · 118th
Changing the Culture of the FDA Act
HR.1328 · 118th
Medical Device Nonvisual Accessibility Act of 2023
Political ProfileWhere HIMS sits in Washington
bipartisan
HIMS reacts sharply to FDA/DEA actions on compounded GLP-1s and telehealth prescribing rules, though many moves are company-specific news rather than broad legislation.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA/FTC scrutiny of compounded GLP-1 marketing
- DEA telehealth prescribing restrictions
- state medical board telehealth licensing rules
- FTC advertising and subscription-cancellation enforcement
Regulatory opportunities
- permanent Medicare telehealth flexibility
- removal of in-person prescribing requirements
- price-transparency and cash-price disclosure rules (HR.4822)
- expanded coverage of virtual mental health
LobbyingWho's hired to advocate for HIMS
Alliance for Connected CareAmerican Telemedicine Association
Member intelligence layer
Live signals + predictions for HIMS — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades HIMS
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout HIMS & political exposure
Does Hims & Hers Health, Inc. (HIMS) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Hims & Hers Health, Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Which Trump cabinet officials own HIMS stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in HIMS on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded HIMS stock?
2 congressional trades by 1 unique members of Congress, most recently on 2025-08-04. See the Congressional Trading panel for politician-by-politician breakdown.
What is HIMS political risk profile?
Government dependence: 12/100. Lobbying intensity: 22/100. Political signal: medium. Donor party split: bipartisan.
How does GovGreed track HIMS political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. HIMS data is updated daily from these official federal sources.